Sanofi SNY
NASDAQ SNY
$41.60 -0.36 (-0.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Sanofi (SNY) Equity Income (2009 - 2026)

Updated

Sanofi's Equity Income was -$10.46 million in the quarter ended Jun 30, 2026, compared with $48.67 million a year earlier.

Analysis

Sanofi (SNY) Equity Income (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Sanofi's Equity Income was -$177.59 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was $327.65 million, up 269.2% from the prior year.

  • Equity Income shows a five-year compound annual growth rate of -4.2% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Equity Income was $88.75 million in the year ended Dec 31, 2024 (-72.0%), $316.94 million in the year ended Dec 31, 2023 (+241.7%), $92.75 million in the year ended Dec 31, 2022 (+101.0%) and $46.15 million in the year ended Dec 31, 2021 (-88.6%).
  • Quarterly Equity Income has moved between -$277.04 million (the quarter ended Dec 31, 2025) and $200.36 million (the quarter ended Jun 30, 2023) over five years.
  • Compared with a year earlier, Equity Income was higher in two of the last four quarters, with an average decline of 26.0%.
  • The best year-over-year quarter for Equity Income over five years was the quarter ended Sep 30, 2023 (growth of 902.5%); the worst was the quarter ended Dec 31, 2021 (a decline of 89.6%).
  • Per Business Quant data, SNY's Equity Income in the three quarters before the quarter ended Jun 30, 2026 was $12.88 million (quarter ended Mar 31, 2026), -$277.04 million (quarter ended Dec 31, 2025) and $97.03 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -10.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Sanofi 50.73 Bn 17.66 Bn 10.79 Bn -10.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.46 Mn
Mar 31, 2026 12.88 Mn
Dec 31, 2025 -180.43 Mn
Sep 30, 2025 97.03 Mn
Jun 30, 2025 48.67 Mn
Mar 31, 2025 44.18 Mn
Dec 31, 2024 -5.34 Mn
Sep 30, 2024 80.17 Mn
Jun 30, 2024 22.61 Mn
Mar 31, 2024 -46.71 Mn
Dec 31, 2023 -146.33 Mn
Sep 30, 2023 70.76 Mn
Jun 30, 2023 -69.69 Mn
Mar 31, 2023 12.88 Mn
Dec 31, 2022 3.06 Mn
Sep 30, 2022 7.06 Mn
Jun 30, 2022 29.88 Mn
Mar 31, 2022 33.67 Mn
Dec 31, 2021 20.59 Mn
Sep 30, 2021 -5.90 Mn
API Access

Sanofi Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=SNY&period=max&api_key=YOUR_API_KEY